Sakar Healthcare Ltd.
| BSE: 538377 | Sector: Health care |
| NSE: SAKAR | ISIN Code: INE732S01012 |
| BSE 05:30 | 01 Jan | Sakar Healthcare Ltd |
| NSE 00:00 | 19 Apr | 105.25 |
-6.25 (-5.61%) |
OPEN
106.20 |
HIGH
109.90 |
LOW
103.00 |
| OPEN | |
| PREVIOUS CLOSE | |
| VOLUME | |
| 52-Week high | 0.00 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 0 |
| Buy Price | |
| Buy Qty | |
| Sell Price | |
| Sell Qty |
Sakar Healthcare Ltd. (SAKAR) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 965.50 | 12.50 | 1.31 | 13266.48 |
| Cipla | 946.60 | 7.90 | 0.84 | 12659.15 |
| Sun Pharma.Inds. | 640.30 | -5.75 | -0.89 | 12531.93 |
| Dr Reddy's Labs | 4970.55 | 77.55 | 1.58 | 11850.40 |
| Lupin | 1061.45 | 5.60 | 0.53 | 11025.66 |
| Apollo Hospitals | 3155.55 | 95.35 | 3.12 | 9794.50 |
| Glenmark Pharma. | 578.95 | 7.05 | 1.23 | 6712.63 |
| Alkem Lab | 2746.00 | -44.45 | -1.59 | 6677.08 |
| Cadila Health. | 527.30 | 0.30 | 0.06 | 6347.40 |
| Torrent Pharma. | 2595.40 | -23.75 | -0.91 | 6168.44 |
| Divi's Lab. | 3805.15 | -18.55 | -0.49 | 5310.57 |
| Ipca Labs. | 2173.10 | 29.90 | 1.40 | 4337.82 |
| Piramal Enterp. | 1662.95 | -56.55 | -3.29 | 4219.19 |
| Alembic Pharma | 1000.10 | -0.50 | -0.05 | 4132.55 |
| Abbott India | 14702.45 | -260.50 | -1.74 | 4093.14 |
| Glaxosmi. Pharma | 1424.50 | -45.10 | -3.07 | 3224.68 |
| Jubilant Pharmo | 770.70 | 46.60 | 6.44 | 3139.90 |
| Sanofi India | 7758.65 | -292.05 | -3.63 | 2901.10 |
| Laurus Labs | 440.75 | -5.40 | -1.21 | 2797.34 |
| Gland Pharma | 2764.25 | 135.15 | 5.14 | 2633.24 |
Quick Links for Sakar Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
